Pretreatment Sarcopenia and MRI-Based Radiomics to Predict the Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Open Access
- 28 June 2024
- journal article
- research article
- Published by MDPI AG in Bioengineering
- Vol. 11 (7) , 663
Abstract
The association between sarcopenia and the effectiveness of neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) remains uncertain. This study aims to examine the potential of sarcopenia as a predictive factor for the response to NAC in TNBC, and to assess whether its combination with MRI radiomic signatures can improve the predictive accuracy. We collected clinical and pathological information, as well as pretreatment breast MRI and abdominal CT images, of 121 patients with TNBC who underwent NAC at our hospital between January 2012 and September 2021. The presence of pretreatment sarcopenia was assessed using the L3 skeletal muscle index. Clinical models were constructed based on independent risk factors identified by univariate regression analysis. Radiomics data were extracted on breast MRI images and the radiomics prediction models were constructed. We integrated independent risk factors and radiomic features to build the combined models. The results of this study demonstrated that sarcopenia is an independent predictive factor for NAC efficacy in TNBC. The combination of sarcopenia and MRI radiomic signatures can further improve predictive performance.Keywords
Funding Information
- National Natural Science Foundation of China (81202085, 2017M613430, 2018T111158, 2020YFS0273, 2023YFS0171)
- China Postdoctoral Science Foundation (81202085, 2017M613430, 2018T111158, 2020YFS0273, 2023YFS0171)
- Key Research and Development Project of Sichuan Province (81202085, 2017M613430, 2018T111158, 2020YFS0273, 2023YFS0171)
This publication has 41 references indexed in Scilit:
- Breast MRI radiomics and machine learning-based predictions of response to neoadjuvant chemotherapy – How are they affected by variations in tumor delineation?Computational and Structural Biotechnology Journal, 2023
- Hematologic toxicities, sarcopenia, and body composition change in breast cancer patients undergoing neoadjuvant chemotherapySupportive Care in Cancer, 2023
- Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective studyeClinicalMedicine, 2023
- Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?The Breast, 2022
- Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancerMagnetic Resonance Materials in Physics, Biology and Medicine, 2021
- Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter studyEBioMedicine, 2021
- Sarcopenia and mortality in cancer: A meta-analysisOsteoporosis and Sarcopenia, 2021
- Body composition and breast cancer risk and treatment: mechanisms and impactBreast Cancer Research and Treatment, 2021
- Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic reviewBreast Cancer Research and Treatment, 2019
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell SequencingCell, 2018